UK approves GSK's Covid antibody drug that slashes risk of death and hospitalisation

Sotrovimab, sold under the brand name Xevudy, cuts the risk of hospitalisation by 79 per cent among those at risk from the virus. But there are fears it may be less effective against Omicron.

from Health News | Mail Online https://ift.tt/31iDxbb

Comentarii

Postări populare de pe acest blog

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

The Best Food, Drink, and Home Service Subscriptions to Give as Wedding Gifts

6 Easy Mother’s Day Gifts for the Mom Who Says She Doesn’t Want Anything